Cibacron blue-induced enhancement of agonist binding to cholecystokinin (CCK) receptors in solubilized pancreatic membranes.
The pancreatic receptor for cholecystokinin (CCK) typifies many G protein-coupled receptors in that its ability to bind agonist can be reduced by GTP or the solubilization of membranes. We found, however, that a dye, cibacron blue, caused up to a 6-fold increase in binding of the CCK receptor agonist, 125I-CCK-8, to rat pancreatic membranes solubilized with digitonin. Binding optimally enhanced in this manner was comparable to binding of 125I-CCK-8 to native membranes with respect to time-course, maximal amount bound, reversibility, and sensitivity to inhibition by various CCK receptor ligands. Increases in affinity of the CCK receptor for CCK-8 accounted fully for the enhancement of binding of 125I-CCK-8. Cibacron blue did not enhance binding of 125I-CCK-8 to native membranes, and also failed to enhance binding of the CCK receptor antagonist, [3H]L-364,718, to solubilized or native membranes. The ability of cibacron blue to enhance binding of agonist but not that of antagonist suggests that this dye may mimic or perhaps stimulate the effects of G protein on CCK receptors. Such a phenomenon may provide new insights into the mechanisms by which receptors distinguish agonists from antagonists.
Yuan
D S
DS
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Wank
S A
SA
Gardner
J D
JD
D000818:Animals; D001570:Benzodiazepinones / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002846:Chromatography, Affinity / Q000379:methods; D004396:Coloring Agents / Q000494:pharmacology; D020109:Devazepide; D004072:Digitonin; D004347:Drug Interactions; D019204:GTP-Binding Proteins / Q000378:metabolism*; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D007457:Iodine Radioisotopes; D008297:Male; D008566:Membranes / Q000378:metabolism; D010179:Pancreas / Q000378:metabolism*; D010671:Phenylurea Compounds; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000187:drug effects* / Q000302:isolation & purification / Q000378:metabolism; D012844:Sincalide / Q000037:antagonists & inhibitors / Q000378:metabolism; D014227:Triazines / Q000494:pharmacology*
D001570:Benzodiazepinones; D004396:Coloring Agents; D007457:Iodine Radioisotopes; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin; D014227:Triazines; C058121:L 365260; D016244:Guanosine 5'-O-(3-Thiotriphosphate); C012842:Cibacron Blue F 3GA; D019204:GTP-Binding Proteins; D020109:Devazepide; D004072:Digitonin; D012844:Sincalide